{"id":10711,"date":"2007-03-08T21:18:00","date_gmt":"2007-03-08T20:18:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/rassegna-stampa-farmaceutica-dal-5-all8-marzo-di-aboutpharma\/"},"modified":"2007-03-08T21:18:00","modified_gmt":"2007-03-08T20:18:00","slug":"rassegna-stampa-farmaceutica-dal-5-all8-marzo-di-aboutpharma","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/rassegna-stampa-farmaceutica-dal-5-all8-marzo-di-aboutpharma\/","title":{"rendered":"PHARMACEUTICAL PRESS REVIEW from 5 to 8 March of AboutPharma"},"content":{"rendered":"
\n
 PHARMACEUTICAL PRESS REVIEW from 5 to 8 March of AboutPharma<\/span> <\/div>\n
 <\/div>\n
Transgene: results down in 2006<\/strong>
(Les Echos online \u2013 March 8, 2007)
Transgene, a French company specializing in biotechnology, announced that it recorded a net loss of 22 million euros in 2006. The company has declared that 2007 will be a key year, above all for the results of the trials on 3 products.
http:\/\/www.aboutpharma.it\/notizia.asp?id=12891<\/a><\/div>\n
 <\/div>\n
Relaunch of the pharmaceutical sector: Comparison of Companies-State-Regions<\/strong>
(Il Sole 24 Ore: page 21 \u2013 8 March 2007)
The State-Regions confrontation has begun for the relaunch of the pharmaceutical sector. The companies presented a platform from which to start defining a 'new drug policy': one of the ways forward for innovation is the tax exemption of the 50% of the increase in spending on R&D investments over the previous year. For Farmindustria, the increase in the diffusion of off-patent drugs is also fine, but without creating a 'protected' generic market. Assogenerici, on the other hand, is asking for less bureaucracy to obtain marketing authorizations and the cancellation of Italian-style patent protection. On over-the-counter medicines, ANIFA would like an increase in the offer with the transition from prescription to self-medication and with the use of brands.
http:\/\/www.aboutpharma.it\/notizia.asp?id=12890<\/a><\/div>\n
 <\/div>\n
Boiron: growing turnover of 5% <\/strong>
(Les Echos online \u2013 March 8, 2007)
Boiron, a French company specializing in homeopathy, in these first months of 2007 achieved a turnover that increased by 5% compared to the loss of 0.4% achieved in the same period of 2006. In 2006 the acquisition of Dolisos, which took place in 2004 , still had repercussions on costs, which amounted to 8.5 million euros. In Russia, the subsidiary created in 2005 has given a lot of satisfaction: 4 million euros of packages marketed.
http:\/\/www.aboutpharma.it\/notizia.asp?id=12889<\/a><\/div>\n
 <\/div>\n
Acambis: change of CEO and restructuring plan<\/strong>
(The Financial Times online - March 8, 2007)
Acambis has decided to change the top management of the company. Gordon Cameron, who has been in office for 3 years as CEO, will be replaced by Ian Garland, who comes from Arrow Therapeutics, a biotech group bought by AstraZeneca last June. The decision was taken as part of a restructuring plan which aims to reduce costs by one fifth.
http:\/\/www.aboutpharma.it\/notizia.asp?id=12888<\/a><\/div>\n
 <\/div>\n
"False 'miracle' drugs. They will go to trial in four"<\/strong>
(la Repubblica Milan page II \u2013 8 March 2007)
Prosecutor Francesco Prete has asked for the indictment of 4 people: the inventor of Biotex, his wife and 2 doctors. They had invented this product calling it 'miraculous' for the cure of all diseases, in reality it was a dietary supplement. The charge is of conspiracy, fraud and abusive exercise of the profession.
http:\/\/www.aboutpharma.it\/notizia.asp?id=12887<\/a><\/div>\n
 <\/div>\n
"Cosmo Pharma cuts IPO fork"<\/strong>
(Bloomberg Finance & Mer<\/p>","protected":false},"excerpt":{"rendered":"

 RASSEGNA STAMPA FARMACEUTICA dal 5 all’8 marzo di AboutPharma    Transgene: risultati in ribasso nel 2006 (Les Echos online – 8 marzo 2007) Transgene, società francese specializzata nelle biotecnologie, ha annunciato di avere registrato nel 2006 una perdita netta pari a 22 mln di euro. L’azienda ha dichiarato che il 2007 sarà un anno chiave, …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-10711","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/10711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=10711"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/10711\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=10711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=10711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=10711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}